Cargando…
HER2阳性非小细胞肺癌诊断及治疗进展
Lung cancer is the most common malignancy in the world and the leading cause of cancer death. Human epidermal growth factor receptor 2 (HER2) positive non-small cell lung cancer (NSCLC) refers to the NSCLC caused by mutation, amplification or overexpression of the HER2 gene, resulting in its dysfunc...
Autores principales: | Chenyi, REN, He, CAO, Jing, ZHENG, Wenjia, SUN, Jianya, ZHOU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186255/ https://www.ncbi.nlm.nih.gov/pubmed/37183644 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.14 |
Ejemplares similares
-
RET融合阳性晚期非小细胞肺癌治疗进展
Publicado: (2021) -
驱动基因阳性非小细胞肺癌免疫治疗进展
Publicado: (2022) -
ALK阳性非小细胞肺癌的诊断
Publicado: (2015) -
ALK阳性非小细胞肺癌靶向治疗研究进展
Publicado: (2014) -
非小细胞肺癌免疫治疗进展
Publicado: (2014)